Select a community
All Communities
Home > Community Treatment Reports > Robitussin (guaifenesin) Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Robitussin (guaifenesin) Treatment Report

Generic Name: Guaifenesin

What is Robitussin? Robitussin is a brand of cold and cough medicines produced by Wyeth Consumer Healthcare. Robitussin products are available over the counter in many countries worldwide. The cough suppressant used in Robitussin products is dextromethorphan. The expectorant used is guaifenesin. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.

Wyeth's Robitussin site


Reasons taken

16 patients in the community are taking or have taken Robitussin.

Reason # Patients Percentage of patients
Other 8 50%
Cough 2 12%
General health 1 6%
disease-related symptoms 1 6%
Emotional lability 1 6%
Persistent cough 1 6%
sinus congestion 1 6%
Support another treatment 1 6%

Other treatments patients are taking for Other include Walking Stick/Cane, MRI, and Levothyroxine.

Dosages

Based on the patients currently taking Robitussin.

Top 10 (Show all)

All (Show top 10)

  100mg/5mL as needed 2tbs. as needed 2 x 100 mg/5 mL as needed as needed daily 2 tbs. daily 4 tbs. daily 6 tps. daily 100 mg/5 mL daily 4 x 100 mg/5 mL daily 20 x 100 mg/5 mL daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Robitussin or how long patients were taking Robitussin before stopping.

Currently Taking Robitussin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
2
0
3

Stopped Taking Robitussin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
1
0
0
0
Why Patients Stopped Taking Robitussin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 1 50% Other: 50%
Course of treatment ended 1 50% Course of treatment ended: 50%

Report created on November 08, 2009.